For instance, small-molecule drugs conjugated with Gal or GalNAc, such as betulin, can specifically recognize and enter ASGR1-expressing liver cancer cells, exerting targeted anti-tumor effects through mechanisms like oxidative stress (121). Here, ASGR1 is linked to liver cancer.